Medicinal – Page 5

Cwh8 moonlights as a farnesyl pyrophosphate phosphatase and is essential for farnesol biosynthesis in Candida albicans

mycolabadmin

Candida albicans is a common fungus that causes serious infections in people with weakened immune systems. The fungus produces a molecule called farnesol that prevents it from growing in long filaments, which are associated with virulence. Researchers discovered that an enzyme called Cwh8 is absolutely essential for making farnesol, and when this enzyme is missing, the fungus becomes highly sensitive to the antifungal drug fluconazole, suggesting a potential strategy to overcome drug resistance.

Clinically proven natural products against breast cancer, with mechanistic insights

mycolabadmin

This comprehensive review examines ten natural products that have been proven in clinical studies to help fight breast cancer. These products—including omega-3 fatty acids from fish, compounds in broccoli sprouts, garlic, soy, curcumin from turmeric, and green tea—work by triggering cancer cells to self-destruct, stopping their growth, and preventing blood vessel formation that feeds tumors. What makes these findings especially promising is that these natural products appear to work well alongside conventional treatments while causing minimal side effects, offering patients additional options for managing this serious disease.

Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review

mycolabadmin

This review examines two emerging psychiatric treatments—ketamine and psilocybin—for treating hard-to-treat mental health conditions in children and teenagers. Both work by affecting brain chemicals differently than traditional medications and can provide rapid symptom relief, sometimes within hours or days rather than weeks. The study found promising results for depression, anxiety, PTSD, and bipolar disorder, though researchers emphasize that more studies are needed to ensure these treatments are safe for developing brains and that careful ethical guidelines must be established.

Psilocybin’s effects on cognition and creativity: A scoping review

mycolabadmin

This comprehensive review examines how psilocybin affects thinking abilities and creativity. Researchers found that large doses initially impair mental performance during the experience, but small doses may enhance creativity. Importantly, the cognitive effects appear to improve after the acute effects wear off, suggesting initial impairment doesn’t cause lasting damage. The review emphasizes the need for more rigorous long-term studies to better understand psilocybin’s effects on brain function.

Synergistic immuno-modulatory activity in human macrophages of a medicinal mushroom formulation consisting of Reishi, Shiitake and Maitake

mycolabadmin

Researchers studied a combination of three medicinal mushroom extracts to see if they work better together than separately. They tested this formula on human immune cells called macrophages and found that the combination was significantly more powerful at boosting immune responses than any single mushroom extract alone. This synergistic effect means the three mushrooms enhance each other’s immune-stimulating properties, suggesting this formula combination could have potential therapeutic benefits for immune support.

Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis

mycolabadmin

This comprehensive analysis of 10 clinical trials shows that psilocybin, a compound from magic mushrooms, can rapidly reduce depression symptoms starting within one day of administration and maintain these benefits for up to 6 months. Higher doses and two treatment sessions produced better results than single lower doses. While psilocybin did raise blood pressure temporarily, it was generally well-tolerated with dropout rates similar to placebo.

A sense of the bigger picture: A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use

mycolabadmin

This research explored how 15 people with bipolar disorder who used psilocybin mushrooms experienced the effects. Many reported benefits like reduced depression and improved outlook on life, but some experienced negative effects including sleep problems and increased manic episodes. The study identified important factors that influenced outcomes, such as whether people used other drugs simultaneously, whether they used psilocybin alone or with others, and how much sleep they had before use. The researchers concluded that while psilocybin shows promise for bipolar depression, more careful clinical research is needed to ensure safety.

An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science

mycolabadmin

This review examines how mathematical models that predict how drugs and chemicals move through the body could be better used in forensic science to help explain cause of death and interpret toxicology evidence. Currently, only a few such models have been specifically developed for forensic purposes, though many exist for common drugs like opioids, cocaine, and alcohol. A major challenge is accounting for how drug concentrations change after death, which can make it harder to determine what the concentration was when the person died.

How Do Cyclodextrins and Dextrans Affect the Gut Microbiome? Review of Prebiotic Activity

mycolabadmin

Cyclodextrins and dextrans are substances commonly used in medicines that may have unexpected health benefits for your gut bacteria. Research shows these compounds can help beneficial bacteria like Lactobacillus and Bifidobacterium grow better in your digestive system. When these good bacteria ferment these substances, they produce helpful compounds called short-chain fatty acids that improve overall gut health and may help with conditions like obesity and inflammation.

Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential

mycolabadmin

Psychedelic drugs like LSD and psilocybin are substances that alter perception and consciousness. Research shows they may help treat serious mental health conditions including depression, anxiety, and PTSD by affecting how the brain forms new connections. These substances are relatively safe compared to many legal drugs, and scientists believe they could revolutionize mental health treatment when used properly under medical supervision.

Research Topic: Medicinal